These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1677459)

  • 1. Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid.
    Prior R; Mönning U; Schreiter-Gasser U; Weidemann A; Blennow K; Gottfries CG; Masters CL; Beyreuther K
    Neurosci Lett; 1991 Mar; 124(1):69-73. PubMed ID: 1677459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay.
    Henriksson T; Barbour RM; Braa S; Ward P; Fritz LC; Johnson-Wood K; Chung HD; Burke W; Reinikainen KJ; Riekkinen P
    J Neurochem; 1991 Mar; 56(3):1037-42. PubMed ID: 1899691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluid.
    Chong JK; Miller BE; Ghanbari HA
    Life Sci; 1990; 47(13):1163-71. PubMed ID: 2122149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.
    Pirttilä T; Kim KS; Mehta PD; Frey H; Wisniewski HM
    J Neurol Sci; 1994 Dec; 127(1):90-5. PubMed ID: 7699397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of amyloid beta protein precursors harboring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA.
    Kitaguchi N; Tokushima Y; Oishi K; Takahashi Y; Shiojiri S; Nakamura S; Tanaka S; Kodaira R; Ito H
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1453-9. PubMed ID: 2106318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process.
    Sjögren M; Davidsson P; Gottfries J; Vanderstichele H; Edman A; Vanmechelen E; Wallin A; Blennow K
    Dement Geriatr Cogn Disord; 2001; 12(4):257-64. PubMed ID: 11351137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.
    Van Nostrand WE; Wagner SL; Shankle WR; Farrow JS; Dick M; Rozemuller JM; Kuiper MA; Wolters EC; Zimmerman J; Cotman CW
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2551-5. PubMed ID: 1557359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta/A4 protein precursor is bound to neurofibrillary tangles in Alzheimer-type dementia.
    Yamaguchi H; Ishiguro K; Shoji M; Yamazaki T; Nakazato Y; Ihara Y; Hirai S
    Brain Res; 1990 Dec; 537(1-2):318-22. PubMed ID: 1982242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease.
    Palmert MR; Usiak M; Mayeux R; Raskind M; Tourtellotte WW; Younkin SG
    Neurology; 1990 Jul; 40(7):1028-34. PubMed ID: 2113204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.
    Nägga K; Gottfries J; Blennow K; Marcusson J
    Dement Geriatr Cogn Disord; 2002; 14(4):183-90. PubMed ID: 12411760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of beta-amyloid protein deposits in brains of transgenic mice.
    Quon D; Wang Y; Catalano R; Scardina JM; Murakami K; Cordell B
    Nature; 1991 Jul; 352(6332):239-41. PubMed ID: 1906990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshifted beta-amyloid precursor protein (APP+1) is a secretory protein, and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology.
    Hol EM; van Dijk R; Gerez L; Sluijs JA; Hobo B; Tonk MT; de Haan A; Kamphorst W; Fischer DF; Benne R; van Leeuwen FW
    J Biol Chem; 2003 Oct; 278(41):39637-43. PubMed ID: 12900421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization.
    Ghiso J; Tagliavini F; Timmers WF; Frangione B
    Biochem Biophys Res Commun; 1989 Aug; 163(1):430-7. PubMed ID: 2476128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells.
    Matsumoto A; Fujiwara Y
    Biochem Biophys Res Commun; 1991 Mar; 175(2):361-5. PubMed ID: 1902089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.
    Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ;
    J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.
    Oltersdorf T; Fritz LC; Schenk DB; Lieberburg I; Johnson-Wood KL; Beattie EC; Ward PJ; Blacher RW; Dovey HF; Sinha S
    Nature; 1989 Sep; 341(6238):144-7. PubMed ID: 2506449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.